EGEN-001
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for EGEN-001, covering 2013-03-26 to 2017-11-30. Get the full timeline:
Most recent: Clinical Trial Update: EGEN-001 in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer [Phase 2]